Post-Gastric Bypass Hypoglycemia

Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT01933490
Collaborator
(none)
10
1
3
12
0.8

Study Details

Study Description

Brief Summary

Post-gastric bypass hyperinsulinemic hypoglycemia is a recently described disorder occurring in some patients after gastric bypass surgery for obesity. The pathogenesis is incompletely understood but involves a robust insulin response to ingested carbohydrate. The resultant hyperinsulinemia sometimes produces hypoglycemia with neuroglycopenia, confusion and even loss of consciousness. Various treatments have been recommended including low carbohydrate diets, coingestion of the medication acarbose with carbohydrate containing meals, partial pancreatectomy and even total pancreatectomy. None is completely satisfactory. We propose to test two new potential treatments. Using a design with random assignment of three conditions we plan to compare, in 10 patients with post-gastric bypass hyperinsulinemic hypoglycemia, a high carbohydrate test meal (control condition), a high carbohydrate test meal after pre-treatment with rapid acting aspart insulin (insulin condition), and a high fructose, low glucose test meal with carbohydrate and caloric content similar to the control meal (fructose condition).

Condition or Disease Intervention/Treatment Phase
  • Other: high carbohydrate test meal
  • Other: high carbohydrate test meal after pre-treatment with rapid acting aspart insulin
  • Other: high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal
N/A

Detailed Description

Post-gastric bypass hyperinsulinemic hypoglycemia is a recently described disorder occurring in some patients after gastric bypass surgery for obesity. The pathogenesis is incompletely understood but involves a robust insulin response to ingested carbohydrate. The resultant hyperinsulinemia sometimes produces hypoglycemia with neuroglycopenia, confusion and even loss of consciousness. Various treatments have been recommended including low carbohydrate diets, coingestion of the medication acarbose with carbohydrate containing meals, partial pancreatectomy and even total pancreatectomy. None is completely satisfactory. We propose to test two new potential treatments. Using a design with random assignment of three conditions we plan to compare, in 10 patients with post-gastric bypass hyperinsulinemic hypoglycemia, a high carbohydrate test meal (control condition), a high carbohydrate test meal after pre-treatment with rapid acting aspart insulin (insulin condition), and a high fructose, low glucose test meal with carbohydrate and caloric content similar to the control meal (fructose condition). The hypothesis to be tested are 1) pretreatment with aspart insulin will prevent, or at least reduce, the occurrence of hypoglycemia and 2) substitution of fructose for glucose in the test meal will prevent, or at least reduce, the occurrence of hypoglycemia. Plasma glucose and serum insulin will be sampled before and for four hours after the three test conditions. The primary study endpoint will be the occurrence or not of plasma glucose < 60 mg/dL after the test meals. The control meal will be compared to the insulin pre-treated test meal and, in a separate comparison, to the fructose test meal. Secondary endpoints will be comparisons between the control and active treatments in peak postprandial serum insulin, peak postprandial plasma glucose, nadir postprandial plasma glucose, and the 4-hr longitudinal course of plasma glucose measurements.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Aug 1, 2014
Actual Study Completion Date :
Aug 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Other: a high carbohydrate test meal (control condition)

a high carbohydrate test meal (control condition)

Other: high carbohydrate test meal

Other: high carbohydrate test meal after pre-treatment with rapid acting aspart insulin

Other: high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal

Active Comparator: high carbohydrate test meal after pre-treatment

a high carbohydrate test meal after pre-treatment with rapid acting aspart insulin (insulin condition)

Other: high carbohydrate test meal

Other: high carbohydrate test meal after pre-treatment with rapid acting aspart insulin

Other: high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal

Active Comparator: high fructose low glucose test meal

high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal (fructose condition)

Other: high carbohydrate test meal

Other: high carbohydrate test meal after pre-treatment with rapid acting aspart insulin

Other: high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal

Outcome Measures

Primary Outcome Measures

  1. The primary study endpoint will be occurrence or not of plasma glucose < 60 mg/dL during the 4 hours after the test meal (binary endpoint). [4 hours after meal]

    The primary study endpoint will be occurrence or not of plasma glucose < 60 mg/dL during the 4 hours after the test meal (binary endpoint).

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants must be at least 21 years of age

  • History of postprandial hypoglycemia with neuroglycopenia occurring one year or more after gastric bypass surgery

  • History of spontaneous correction of hypoglycemia

  • Normal fasting plasma glucose and serum insulin after a carbohydrate containing mixed meal, demonstration of serum insulin > 50u/UL and plasma glucose < 50mg/dL

Exclusion Criteria:
  • Under 21 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: John Bantle, MD, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT01933490
Other Study ID Numbers:
  • 1306M37181
First Posted:
Sep 2, 2013
Last Update Posted:
Nov 1, 2019
Last Verified:
Oct 1, 2019
Keywords provided by University of Minnesota
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 1, 2019